Medical Care
Global Endocannabinoid System Targeted Therapeutics Market Research Report 2025
- Jul 08, 25
- ID: 348032
- Pages: 77
- Figures: 77
- Views: 2
The global market for Endocannabinoid System Targeted Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Endocannabinoid System Targeted Therapeutics refers to the use of the endocannabinoid system as a therapeutic target to treat some diseases
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Endocannabinoid System Targeted Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endocannabinoid System Targeted Therapeutics.
The Endocannabinoid System Targeted Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Endocannabinoid System Targeted Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Endocannabinoid System Targeted Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GW Pharmaceuticals
MAKScientific
Corbus Pharmaceuticals
Tilray
Pure Green
Avicanna
GB Sciences
Botanix Pharmaceuticals
Therapix Biosciences
Zelira Therapeutics
Segment by Type
Oral
Inhalation
Others
Segment by Application
Autoimmune Disorders
Genetic Disorders
Neurological Disorders
Pain Disorders
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Endocannabinoid System Targeted Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Endocannabinoid System Targeted Therapeutics refers to the use of the endocannabinoid system as a therapeutic target to treat some diseases
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Endocannabinoid System Targeted Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endocannabinoid System Targeted Therapeutics.
The Endocannabinoid System Targeted Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Endocannabinoid System Targeted Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Endocannabinoid System Targeted Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GW Pharmaceuticals
MAKScientific
Corbus Pharmaceuticals
Tilray
Pure Green
Avicanna
GB Sciences
Botanix Pharmaceuticals
Therapix Biosciences
Zelira Therapeutics
Segment by Type
Oral
Inhalation
Others
Segment by Application
Autoimmune Disorders
Genetic Disorders
Neurological Disorders
Pain Disorders
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Endocannabinoid System Targeted Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endocannabinoid System Targeted Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oral
1.2.3 Inhalation
1.2.4 Others
1.3 Market by Application
1.3.1 Global Endocannabinoid System Targeted Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Autoimmune Disorders
1.3.3 Genetic Disorders
1.3.4 Neurological Disorders
1.3.5 Pain Disorders
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Endocannabinoid System Targeted Therapeutics Market Perspective (2020-2031)
2.2 Global Endocannabinoid System Targeted Therapeutics Growth Trends by Region
2.2.1 Global Endocannabinoid System Targeted Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Endocannabinoid System Targeted Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Endocannabinoid System Targeted Therapeutics Market Dynamics
2.3.1 Endocannabinoid System Targeted Therapeutics Industry Trends
2.3.2 Endocannabinoid System Targeted Therapeutics Market Drivers
2.3.3 Endocannabinoid System Targeted Therapeutics Market Challenges
2.3.4 Endocannabinoid System Targeted Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Endocannabinoid System Targeted Therapeutics Players by Revenue
3.1.1 Global Top Endocannabinoid System Targeted Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Endocannabinoid System Targeted Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Endocannabinoid System Targeted Therapeutics Revenue
3.4 Global Endocannabinoid System Targeted Therapeutics Market Concentration Ratio
3.4.1 Global Endocannabinoid System Targeted Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endocannabinoid System Targeted Therapeutics Revenue in 2024
3.5 Global Key Players of Endocannabinoid System Targeted Therapeutics Head office and Area Served
3.6 Global Key Players of Endocannabinoid System Targeted Therapeutics, Product and Application
3.7 Global Key Players of Endocannabinoid System Targeted Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Endocannabinoid System Targeted Therapeutics Breakdown Data by Type
4.1 Global Endocannabinoid System Targeted Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Type (2026-2031)
5 Endocannabinoid System Targeted Therapeutics Breakdown Data by Application
5.1 Global Endocannabinoid System Targeted Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Endocannabinoid System Targeted Therapeutics Market Size (2020-2031)
6.2 North America Endocannabinoid System Targeted Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Endocannabinoid System Targeted Therapeutics Market Size by Country (2020-2025)
6.4 North America Endocannabinoid System Targeted Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Endocannabinoid System Targeted Therapeutics Market Size (2020-2031)
7.2 Europe Endocannabinoid System Targeted Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Endocannabinoid System Targeted Therapeutics Market Size by Country (2020-2025)
7.4 Europe Endocannabinoid System Targeted Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Endocannabinoid System Targeted Therapeutics Market Size (2020-2031)
9.2 Latin America Endocannabinoid System Targeted Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Endocannabinoid System Targeted Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Endocannabinoid System Targeted Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GW Pharmaceuticals
11.1.1 GW Pharmaceuticals Company Details
11.1.2 GW Pharmaceuticals Business Overview
11.1.3 GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Introduction
11.1.4 GW Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
11.1.5 GW Pharmaceuticals Recent Development
11.2 MAKScientific
11.2.1 MAKScientific Company Details
11.2.2 MAKScientific Business Overview
11.2.3 MAKScientific Endocannabinoid System Targeted Therapeutics Introduction
11.2.4 MAKScientific Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
11.2.5 MAKScientific Recent Development
11.3 Corbus Pharmaceuticals
11.3.1 Corbus Pharmaceuticals Company Details
11.3.2 Corbus Pharmaceuticals Business Overview
11.3.3 Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Introduction
11.3.4 Corbus Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
11.3.5 Corbus Pharmaceuticals Recent Development
11.4 Tilray
11.4.1 Tilray Company Details
11.4.2 Tilray Business Overview
11.4.3 Tilray Endocannabinoid System Targeted Therapeutics Introduction
11.4.4 Tilray Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
11.4.5 Tilray Recent Development
11.5 Pure Green
11.5.1 Pure Green Company Details
11.5.2 Pure Green Business Overview
11.5.3 Pure Green Endocannabinoid System Targeted Therapeutics Introduction
11.5.4 Pure Green Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
11.5.5 Pure Green Recent Development
11.6 Avicanna
11.6.1 Avicanna Company Details
11.6.2 Avicanna Business Overview
11.6.3 Avicanna Endocannabinoid System Targeted Therapeutics Introduction
11.6.4 Avicanna Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
11.6.5 Avicanna Recent Development
11.7 GB Sciences
11.7.1 GB Sciences Company Details
11.7.2 GB Sciences Business Overview
11.7.3 GB Sciences Endocannabinoid System Targeted Therapeutics Introduction
11.7.4 GB Sciences Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
11.7.5 GB Sciences Recent Development
11.8 Botanix Pharmaceuticals
11.8.1 Botanix Pharmaceuticals Company Details
11.8.2 Botanix Pharmaceuticals Business Overview
11.8.3 Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Introduction
11.8.4 Botanix Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
11.8.5 Botanix Pharmaceuticals Recent Development
11.9 Therapix Biosciences
11.9.1 Therapix Biosciences Company Details
11.9.2 Therapix Biosciences Business Overview
11.9.3 Therapix Biosciences Endocannabinoid System Targeted Therapeutics Introduction
11.9.4 Therapix Biosciences Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
11.9.5 Therapix Biosciences Recent Development
11.10 Zelira Therapeutics
11.10.1 Zelira Therapeutics Company Details
11.10.2 Zelira Therapeutics Business Overview
11.10.3 Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Introduction
11.10.4 Zelira Therapeutics Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
11.10.5 Zelira Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endocannabinoid System Targeted Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oral
1.2.3 Inhalation
1.2.4 Others
1.3 Market by Application
1.3.1 Global Endocannabinoid System Targeted Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Autoimmune Disorders
1.3.3 Genetic Disorders
1.3.4 Neurological Disorders
1.3.5 Pain Disorders
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Endocannabinoid System Targeted Therapeutics Market Perspective (2020-2031)
2.2 Global Endocannabinoid System Targeted Therapeutics Growth Trends by Region
2.2.1 Global Endocannabinoid System Targeted Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Endocannabinoid System Targeted Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Endocannabinoid System Targeted Therapeutics Market Dynamics
2.3.1 Endocannabinoid System Targeted Therapeutics Industry Trends
2.3.2 Endocannabinoid System Targeted Therapeutics Market Drivers
2.3.3 Endocannabinoid System Targeted Therapeutics Market Challenges
2.3.4 Endocannabinoid System Targeted Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Endocannabinoid System Targeted Therapeutics Players by Revenue
3.1.1 Global Top Endocannabinoid System Targeted Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Endocannabinoid System Targeted Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Endocannabinoid System Targeted Therapeutics Revenue
3.4 Global Endocannabinoid System Targeted Therapeutics Market Concentration Ratio
3.4.1 Global Endocannabinoid System Targeted Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endocannabinoid System Targeted Therapeutics Revenue in 2024
3.5 Global Key Players of Endocannabinoid System Targeted Therapeutics Head office and Area Served
3.6 Global Key Players of Endocannabinoid System Targeted Therapeutics, Product and Application
3.7 Global Key Players of Endocannabinoid System Targeted Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Endocannabinoid System Targeted Therapeutics Breakdown Data by Type
4.1 Global Endocannabinoid System Targeted Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Type (2026-2031)
5 Endocannabinoid System Targeted Therapeutics Breakdown Data by Application
5.1 Global Endocannabinoid System Targeted Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Endocannabinoid System Targeted Therapeutics Market Size (2020-2031)
6.2 North America Endocannabinoid System Targeted Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Endocannabinoid System Targeted Therapeutics Market Size by Country (2020-2025)
6.4 North America Endocannabinoid System Targeted Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Endocannabinoid System Targeted Therapeutics Market Size (2020-2031)
7.2 Europe Endocannabinoid System Targeted Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Endocannabinoid System Targeted Therapeutics Market Size by Country (2020-2025)
7.4 Europe Endocannabinoid System Targeted Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Endocannabinoid System Targeted Therapeutics Market Size (2020-2031)
9.2 Latin America Endocannabinoid System Targeted Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Endocannabinoid System Targeted Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Endocannabinoid System Targeted Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GW Pharmaceuticals
11.1.1 GW Pharmaceuticals Company Details
11.1.2 GW Pharmaceuticals Business Overview
11.1.3 GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Introduction
11.1.4 GW Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
11.1.5 GW Pharmaceuticals Recent Development
11.2 MAKScientific
11.2.1 MAKScientific Company Details
11.2.2 MAKScientific Business Overview
11.2.3 MAKScientific Endocannabinoid System Targeted Therapeutics Introduction
11.2.4 MAKScientific Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
11.2.5 MAKScientific Recent Development
11.3 Corbus Pharmaceuticals
11.3.1 Corbus Pharmaceuticals Company Details
11.3.2 Corbus Pharmaceuticals Business Overview
11.3.3 Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Introduction
11.3.4 Corbus Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
11.3.5 Corbus Pharmaceuticals Recent Development
11.4 Tilray
11.4.1 Tilray Company Details
11.4.2 Tilray Business Overview
11.4.3 Tilray Endocannabinoid System Targeted Therapeutics Introduction
11.4.4 Tilray Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
11.4.5 Tilray Recent Development
11.5 Pure Green
11.5.1 Pure Green Company Details
11.5.2 Pure Green Business Overview
11.5.3 Pure Green Endocannabinoid System Targeted Therapeutics Introduction
11.5.4 Pure Green Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
11.5.5 Pure Green Recent Development
11.6 Avicanna
11.6.1 Avicanna Company Details
11.6.2 Avicanna Business Overview
11.6.3 Avicanna Endocannabinoid System Targeted Therapeutics Introduction
11.6.4 Avicanna Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
11.6.5 Avicanna Recent Development
11.7 GB Sciences
11.7.1 GB Sciences Company Details
11.7.2 GB Sciences Business Overview
11.7.3 GB Sciences Endocannabinoid System Targeted Therapeutics Introduction
11.7.4 GB Sciences Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
11.7.5 GB Sciences Recent Development
11.8 Botanix Pharmaceuticals
11.8.1 Botanix Pharmaceuticals Company Details
11.8.2 Botanix Pharmaceuticals Business Overview
11.8.3 Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Introduction
11.8.4 Botanix Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
11.8.5 Botanix Pharmaceuticals Recent Development
11.9 Therapix Biosciences
11.9.1 Therapix Biosciences Company Details
11.9.2 Therapix Biosciences Business Overview
11.9.3 Therapix Biosciences Endocannabinoid System Targeted Therapeutics Introduction
11.9.4 Therapix Biosciences Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
11.9.5 Therapix Biosciences Recent Development
11.10 Zelira Therapeutics
11.10.1 Zelira Therapeutics Company Details
11.10.2 Zelira Therapeutics Business Overview
11.10.3 Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Introduction
11.10.4 Zelira Therapeutics Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
11.10.5 Zelira Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Endocannabinoid System Targeted Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Oral
Table 3. Key Players of Inhalation
Table 4. Key Players of Others
Table 5. Global Endocannabinoid System Targeted Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Endocannabinoid System Targeted Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Endocannabinoid System Targeted Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Endocannabinoid System Targeted Therapeutics Market Share by Region (2020-2025)
Table 9. Global Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Endocannabinoid System Targeted Therapeutics Market Share by Region (2026-2031)
Table 11. Endocannabinoid System Targeted Therapeutics Market Trends
Table 12. Endocannabinoid System Targeted Therapeutics Market Drivers
Table 13. Endocannabinoid System Targeted Therapeutics Market Challenges
Table 14. Endocannabinoid System Targeted Therapeutics Market Restraints
Table 15. Global Endocannabinoid System Targeted Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Endocannabinoid System Targeted Therapeutics Market Share by Players (2020-2025)
Table 17. Global Top Endocannabinoid System Targeted Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocannabinoid System Targeted Therapeutics as of 2024)
Table 18. Ranking of Global Top Endocannabinoid System Targeted Therapeutics Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Endocannabinoid System Targeted Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Endocannabinoid System Targeted Therapeutics, Headquarters and Area Served
Table 21. Global Key Players of Endocannabinoid System Targeted Therapeutics, Product and Application
Table 22. Global Key Players of Endocannabinoid System Targeted Therapeutics, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Endocannabinoid System Targeted Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Type (2020-2025)
Table 26. Global Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Type (2026-2031)
Table 28. Global Endocannabinoid System Targeted Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Application (2020-2025)
Table 30. Global Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Application (2026-2031)
Table 32. North America Endocannabinoid System Targeted Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Endocannabinoid System Targeted Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Endocannabinoid System Targeted Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Endocannabinoid System Targeted Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Endocannabinoid System Targeted Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Endocannabinoid System Targeted Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Endocannabinoid System Targeted Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Endocannabinoid System Targeted Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Endocannabinoid System Targeted Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 47. GW Pharmaceuticals Company Details
Table 48. GW Pharmaceuticals Business Overview
Table 49. GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product
Table 50. GW Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025) & (US$ Million)
Table 51. GW Pharmaceuticals Recent Development
Table 52. MAKScientific Company Details
Table 53. MAKScientific Business Overview
Table 54. MAKScientific Endocannabinoid System Targeted Therapeutics Product
Table 55. MAKScientific Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025) & (US$ Million)
Table 56. MAKScientific Recent Development
Table 57. Corbus Pharmaceuticals Company Details
Table 58. Corbus Pharmaceuticals Business Overview
Table 59. Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product
Table 60. Corbus Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025) & (US$ Million)
Table 61. Corbus Pharmaceuticals Recent Development
Table 62. Tilray Company Details
Table 63. Tilray Business Overview
Table 64. Tilray Endocannabinoid System Targeted Therapeutics Product
Table 65. Tilray Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025) & (US$ Million)
Table 66. Tilray Recent Development
Table 67. Pure Green Company Details
Table 68. Pure Green Business Overview
Table 69. Pure Green Endocannabinoid System Targeted Therapeutics Product
Table 70. Pure Green Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025) & (US$ Million)
Table 71. Pure Green Recent Development
Table 72. Avicanna Company Details
Table 73. Avicanna Business Overview
Table 74. Avicanna Endocannabinoid System Targeted Therapeutics Product
Table 75. Avicanna Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025) & (US$ Million)
Table 76. Avicanna Recent Development
Table 77. GB Sciences Company Details
Table 78. GB Sciences Business Overview
Table 79. GB Sciences Endocannabinoid System Targeted Therapeutics Product
Table 80. GB Sciences Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025) & (US$ Million)
Table 81. GB Sciences Recent Development
Table 82. Botanix Pharmaceuticals Company Details
Table 83. Botanix Pharmaceuticals Business Overview
Table 84. Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product
Table 85. Botanix Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025) & (US$ Million)
Table 86. Botanix Pharmaceuticals Recent Development
Table 87. Therapix Biosciences Company Details
Table 88. Therapix Biosciences Business Overview
Table 89. Therapix Biosciences Endocannabinoid System Targeted Therapeutics Product
Table 90. Therapix Biosciences Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025) & (US$ Million)
Table 91. Therapix Biosciences Recent Development
Table 92. Zelira Therapeutics Company Details
Table 93. Zelira Therapeutics Business Overview
Table 94. Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Product
Table 95. Zelira Therapeutics Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025) & (US$ Million)
Table 96. Zelira Therapeutics Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report
List of Figures
Figure 1. Endocannabinoid System Targeted Therapeutics Picture
Figure 2. Global Endocannabinoid System Targeted Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Endocannabinoid System Targeted Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Oral Features
Figure 5. Inhalation Features
Figure 6. Others Features
Figure 7. Global Endocannabinoid System Targeted Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Endocannabinoid System Targeted Therapeutics Market Share by Application: 2024 VS 2031
Figure 9. Autoimmune Disorders Case Studies
Figure 10. Genetic Disorders Case Studies
Figure 11. Neurological Disorders Case Studies
Figure 12. Pain Disorders Case Studies
Figure 13. Endocannabinoid System Targeted Therapeutics Report Years Considered
Figure 14. Global Endocannabinoid System Targeted Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Endocannabinoid System Targeted Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Endocannabinoid System Targeted Therapeutics Market Share by Region: 2024 VS 2031
Figure 17. Global Endocannabinoid System Targeted Therapeutics Market Share by Players in 2024
Figure 18. Global Top Endocannabinoid System Targeted Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocannabinoid System Targeted Therapeutics as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Endocannabinoid System Targeted Therapeutics Revenue in 2024
Figure 20. North America Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Endocannabinoid System Targeted Therapeutics Market Share by Country (2020-2031)
Figure 22. United States Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Endocannabinoid System Targeted Therapeutics Market Share by Country (2020-2031)
Figure 26. Germany Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Share by Region (2020-2031)
Figure 34. China Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Endocannabinoid System Targeted Therapeutics Market Share by Country (2020-2031)
Figure 42. Mexico Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Share by Country (2020-2031)
Figure 46. Turkey Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. GW Pharmaceuticals Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
Figure 50. MAKScientific Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
Figure 51. Corbus Pharmaceuticals Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
Figure 52. Tilray Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
Figure 53. Pure Green Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
Figure 54. Avicanna Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
Figure 55. GB Sciences Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
Figure 56. Botanix Pharmaceuticals Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
Figure 57. Therapix Biosciences Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
Figure 58. Zelira Therapeutics Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Endocannabinoid System Targeted Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Oral
Table 3. Key Players of Inhalation
Table 4. Key Players of Others
Table 5. Global Endocannabinoid System Targeted Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Endocannabinoid System Targeted Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Endocannabinoid System Targeted Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Endocannabinoid System Targeted Therapeutics Market Share by Region (2020-2025)
Table 9. Global Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Endocannabinoid System Targeted Therapeutics Market Share by Region (2026-2031)
Table 11. Endocannabinoid System Targeted Therapeutics Market Trends
Table 12. Endocannabinoid System Targeted Therapeutics Market Drivers
Table 13. Endocannabinoid System Targeted Therapeutics Market Challenges
Table 14. Endocannabinoid System Targeted Therapeutics Market Restraints
Table 15. Global Endocannabinoid System Targeted Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Endocannabinoid System Targeted Therapeutics Market Share by Players (2020-2025)
Table 17. Global Top Endocannabinoid System Targeted Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocannabinoid System Targeted Therapeutics as of 2024)
Table 18. Ranking of Global Top Endocannabinoid System Targeted Therapeutics Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Endocannabinoid System Targeted Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Endocannabinoid System Targeted Therapeutics, Headquarters and Area Served
Table 21. Global Key Players of Endocannabinoid System Targeted Therapeutics, Product and Application
Table 22. Global Key Players of Endocannabinoid System Targeted Therapeutics, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Endocannabinoid System Targeted Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Type (2020-2025)
Table 26. Global Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Type (2026-2031)
Table 28. Global Endocannabinoid System Targeted Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Application (2020-2025)
Table 30. Global Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Application (2026-2031)
Table 32. North America Endocannabinoid System Targeted Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Endocannabinoid System Targeted Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Endocannabinoid System Targeted Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Endocannabinoid System Targeted Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Endocannabinoid System Targeted Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Endocannabinoid System Targeted Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Endocannabinoid System Targeted Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Endocannabinoid System Targeted Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Endocannabinoid System Targeted Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 47. GW Pharmaceuticals Company Details
Table 48. GW Pharmaceuticals Business Overview
Table 49. GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product
Table 50. GW Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025) & (US$ Million)
Table 51. GW Pharmaceuticals Recent Development
Table 52. MAKScientific Company Details
Table 53. MAKScientific Business Overview
Table 54. MAKScientific Endocannabinoid System Targeted Therapeutics Product
Table 55. MAKScientific Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025) & (US$ Million)
Table 56. MAKScientific Recent Development
Table 57. Corbus Pharmaceuticals Company Details
Table 58. Corbus Pharmaceuticals Business Overview
Table 59. Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product
Table 60. Corbus Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025) & (US$ Million)
Table 61. Corbus Pharmaceuticals Recent Development
Table 62. Tilray Company Details
Table 63. Tilray Business Overview
Table 64. Tilray Endocannabinoid System Targeted Therapeutics Product
Table 65. Tilray Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025) & (US$ Million)
Table 66. Tilray Recent Development
Table 67. Pure Green Company Details
Table 68. Pure Green Business Overview
Table 69. Pure Green Endocannabinoid System Targeted Therapeutics Product
Table 70. Pure Green Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025) & (US$ Million)
Table 71. Pure Green Recent Development
Table 72. Avicanna Company Details
Table 73. Avicanna Business Overview
Table 74. Avicanna Endocannabinoid System Targeted Therapeutics Product
Table 75. Avicanna Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025) & (US$ Million)
Table 76. Avicanna Recent Development
Table 77. GB Sciences Company Details
Table 78. GB Sciences Business Overview
Table 79. GB Sciences Endocannabinoid System Targeted Therapeutics Product
Table 80. GB Sciences Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025) & (US$ Million)
Table 81. GB Sciences Recent Development
Table 82. Botanix Pharmaceuticals Company Details
Table 83. Botanix Pharmaceuticals Business Overview
Table 84. Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product
Table 85. Botanix Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025) & (US$ Million)
Table 86. Botanix Pharmaceuticals Recent Development
Table 87. Therapix Biosciences Company Details
Table 88. Therapix Biosciences Business Overview
Table 89. Therapix Biosciences Endocannabinoid System Targeted Therapeutics Product
Table 90. Therapix Biosciences Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025) & (US$ Million)
Table 91. Therapix Biosciences Recent Development
Table 92. Zelira Therapeutics Company Details
Table 93. Zelira Therapeutics Business Overview
Table 94. Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Product
Table 95. Zelira Therapeutics Revenue in Endocannabinoid System Targeted Therapeutics Business (2020-2025) & (US$ Million)
Table 96. Zelira Therapeutics Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report
List of Figures
Figure 1. Endocannabinoid System Targeted Therapeutics Picture
Figure 2. Global Endocannabinoid System Targeted Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Endocannabinoid System Targeted Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Oral Features
Figure 5. Inhalation Features
Figure 6. Others Features
Figure 7. Global Endocannabinoid System Targeted Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Endocannabinoid System Targeted Therapeutics Market Share by Application: 2024 VS 2031
Figure 9. Autoimmune Disorders Case Studies
Figure 10. Genetic Disorders Case Studies
Figure 11. Neurological Disorders Case Studies
Figure 12. Pain Disorders Case Studies
Figure 13. Endocannabinoid System Targeted Therapeutics Report Years Considered
Figure 14. Global Endocannabinoid System Targeted Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Endocannabinoid System Targeted Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Endocannabinoid System Targeted Therapeutics Market Share by Region: 2024 VS 2031
Figure 17. Global Endocannabinoid System Targeted Therapeutics Market Share by Players in 2024
Figure 18. Global Top Endocannabinoid System Targeted Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocannabinoid System Targeted Therapeutics as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Endocannabinoid System Targeted Therapeutics Revenue in 2024
Figure 20. North America Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Endocannabinoid System Targeted Therapeutics Market Share by Country (2020-2031)
Figure 22. United States Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Endocannabinoid System Targeted Therapeutics Market Share by Country (2020-2031)
Figure 26. Germany Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Share by Region (2020-2031)
Figure 34. China Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Endocannabinoid System Targeted Therapeutics Market Share by Country (2020-2031)
Figure 42. Mexico Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Share by Country (2020-2031)
Figure 46. Turkey Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. GW Pharmaceuticals Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
Figure 50. MAKScientific Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
Figure 51. Corbus Pharmaceuticals Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
Figure 52. Tilray Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
Figure 53. Pure Green Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
Figure 54. Avicanna Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
Figure 55. GB Sciences Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
Figure 56. Botanix Pharmaceuticals Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
Figure 57. Therapix Biosciences Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
Figure 58. Zelira Therapeutics Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Benzyltrimethylammonium Hydroxide (BTMAH) Market Research Report 2025
Jul 10, 25
Global Allyltrimethylammonium Chloride Market Research Report 2025
Jul 10, 25
Global Calcium Bisglycinate Market Research Report 2025
Jul 10, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232